Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Dr Reddys Laboratories (RDY) Income from Continuing Operations (2016 - 2025)

Historic Income from Continuing Operations for Dr Reddys Laboratories (RDY) over the last 17 years, with Q4 2025 value amounting to $133.6 million.

  • Dr Reddys Laboratories' Income from Continuing Operations fell 1965.63% to $133.6 million in Q4 2025 from the same period last year, while for Dec 2025 it was $651.6 million, marking a year-over-year decrease of 257.8%. This contributed to the annual value of $671.0 million for FY2025, which is 44.91% up from last year.
  • Per Dr Reddys Laboratories' latest filing, its Income from Continuing Operations stood at $133.6 million for Q4 2025, which was down 1965.63% from $183.3 million recorded in Q1 2025.
  • Over the past 5 years, Dr Reddys Laboratories' Income from Continuing Operations peaked at $183.3 million during Q1 2025, and registered a low of $152.0 during Q3 2022.
  • Its 5-year average for Income from Continuing Operations is $131.6 million, with a median of $154.0 million in 2022.
  • As far as peak fluctuations go, Dr Reddys Laboratories' Income from Continuing Operations crashed by 9999.98% in 2022, and later skyrocketed by 11778634501.85% in 2023.
  • Over the past 5 years, Dr Reddys Laboratories' Income from Continuing Operations (Quarter) stood at $11.0 million in 2021, then soared by 962.09% to $116.8 million in 2022, then surged by 45.52% to $170.0 million in 2023, then fell by 2.21% to $166.3 million in 2024, then decreased by 19.66% to $133.6 million in 2025.
  • Its Income from Continuing Operations was $133.6 million in Q4 2025, compared to $183.3 million in Q1 2025 and $166.3 million in Q4 2024.